| Prev Close: | 70.69 |
|---|---|
| Open: | 69.43 |
| Bid: | N/A |
| Ask: | 73.81 x 100 |
| 1y Target Est: | 62.77 |
| Beta: | 0.86 |
| Next Earnings Date: | 22-Jul-13 |
| Day's Range: | 67.90 - 71.20 |
|---|---|
| 52wk Range: | 37.77 - 77.11 |
| Volume: | 1,584,154 |
| Avg Vol (3m): | 1,382,860 |
| Market Cap: | 8.84B |
| P/E (ttm): | 91.36 |
| EPS (ttm): | 0.78 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 6 Ways You Can Profit From Molecular Diagnosticsat Seeking Alpha(Wed, May 22)
- Roche, Sigma teamed up for failed Life Technologies bid: sourcesat Reuters(Tue, May 21)
- Roche, Sigma teamed up for failed Life Technologies bid -sourcesat Reuters(Tue, May 21)
- Opportunities in Hepatitis C and Genomic Technologies: a Wall Street Transcript Interview with David Ferreiro, Executive Director and Senior Analyst at Oppenheimer & Co. Inc.Wall Street Transcript(Tue, May 21)
- Splicing & Dicing Myriad Genetics Amidst the Angelina Jolie Disclosureat Motley Fool(Tue, May 21)
- QIAGEN Downgraded to Strong SellZacks(Tue, May 21)
- The 3 Deadliest Diseases in the U.S.at Motley Fool(Mon, May 20)
- Illumina Inc. Presents at UBS Global Healthcare Conference, May-20-2013 11:30 AMat Seeking Alpha(Mon, May 20)
- UK tries out new model for gene testing in cancer patientsat Reuters(Mon, May 20)
- U.K. to Pilot Illumina Genetic Test for Breast, Ovarian Cancerat Bloomberg(Mon, May 20)
- IBD 50: Top 5 Medical Stocks Include Celgene, Actavisat Investor's Business Daily(Sat, May 18)
- How one bull is sticking with IlluminaoptionMONSTER(Fri, May 17)
- A Portfolio Construction Strategy with an Emphasis on High-Innovation, Breakthrough Biotech and Pharmaceutical CompaniesWall Street Transcript(Thu, May 16)
- Gene-Testing Dispute Focuses on How Much a Patient Should Knowat Bloomberg(Thu, May 16)
- Illumina Launches BaseSpace® AppsBusiness Wire(Thu, May 16)
Press Releases
- Illumina Launches BaseSpace® AppsBusiness Wire(Thu, May 16)
- Illumina Announces Partnerships to Automate TruSeq® and Nextera® Sample Preparation KitsBusiness Wire(Wed, May 15)
- Illumina to Webcast Live Presentation at Upcoming Investment Conferences in MayBusiness Wire(Wed, May 1)
Reports
- ILMN: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(May 23)
- ValuEngine Detailed Valuation Report for ILMNValuEngine, Inc.(May 23)
- ValuEngine Industry Report for Medical-biomed/geneticsValuEngine, Inc.(May 23)